ABSTRACT Sox17 is a transcription factor that is required for maintenance of the definitive endoderm in mouse embryos. By expression profiling of wild-type and mutant embryos and Sox17-overexpressing hepatoma cells, we identified genes with Sox17-dependent expression. Among the genes that were up-regulated in Sox17-null embryos and down-regulated by Sox17-expressing HepG2 cells is a set of genes that are expressed in the developing liver, suggesting that one function of Sox17 is the repression of liver gene expression, which is compatible with a role for Sox17 in maintaining the definitive endoderm in a progenitor state. Consistent with these findings, Sox17 -/-cells display a diminished capacity to contribute to the definitive endoderm when transplanted into wild-type hosts. Analysis of gene ontology further revealed that many genes related to heart development were downregulated in Sox17-null embryos. This is associated with the defective development of the heart in the mutant embryos, which is accompanied by localised loss of Myocd-expressing cardiogenic progenitors and the malformation of the anterior intestinal portal.
Introduction
Endoderm specification and differentiation during embryogenesis in frogs and fish involves transcriptional activation of zinc finger GATA factors, Mix-homeodomain proteins and High Mobility Group SOX proteins by TGF/Nodal signalling and T-box and POU-domain transcription factors (Kiefer, 2003; Lunde et al., 2004; Reim et al., 2004; Shivdasani, 2002; Stainier, 2002; Woodland and Zorn, 2008; Zorn and Wells, 2007; Zorn and Wells, 2009) . A similar set of genes including Mix/Mixer, Sox17 and Foxa is associated with endoderm formation in mouse, frogs and fish, but their function and regulation differ in mouse development.
The mouse Mixl1 gene is expressed in the primitive streak where the endoderm progenitors reside but not in the definitive endoderm (Pearce and Evans, 1999) , unlike in Xenopus where Mix/Mixer expression is endoderm-specific. Mixl1 function is critical for the generation of definitive endoderm in the mouse.
Int. J. Dev. Biol. 55: 45-58 (2011) Foxa2 is severely reduced in Sox17 -/-mouse embryos (Kanai-Azuma et al., 2002) , but it is not clear whether they are direct transcriptional targets of Sox17.
At present, the transcriptional targets of Sox17 in the mouse embryo at early-organogenesis when the nullmutant phenotype first manifests have not been identified. Previous studies dealing with Sox17-dependent gene expression in mammalian cells have used mouse or human embryonic stem (ES) cells, in which Sox17 was over-expressed. Results conflicted between the two stem cell types, with Sox17 inducing molecular characteristics of definitive endoderm in human ES cells (Seguin et al., 2008) but those of extraembryonic endoderm in mouse ES cells (Niakan et al., 2010) . However, in mouse ES cells, Sox17 can induce both definitive and visceral endoderm differentiation under some circumstances (Qu et al., 2008) . The variation in results between in vitro models suggests that Sox17-dependent changes in the transcriptome and the identification of potential Sox17 transcriptional targets is influenced by the inherent propidentify possible Sox17 target genes, we compared the changes in gene expression profiles of mutant embryos with those resulting from Sox17-overexpression in HepG2 cells. The findings show that changes in Sox17 activity impact on the genetic activity associated with endoderm development. Embryological analysis Real-time quantitative RTPCR analysis was performed on cDNA generated from RNA samples of E8.25 Sox17 +/+ and Sox17 -/-embryos. Expression levels are shown relative to wild-type. Gapd was the reference gene. Error bars indicate standard error of the mean. N=3 for each assay. **Significant difference at p<0.01 by two-tailed t-test from Sox17 +/+ embryos.
erties of the cell model used.
In this study, we examined gene expression profiles in the mouse embryo, in which Sox17 has been shown to be required for development of the definitive but not visceral endoderm, to identify Sox17-dependent changes in gene transcription. To further shows that Sox17-null cells are less efficient in contributing to the definitive endoderm. Loss of Sox17 in the endoderm also disrupts form-shaping activity in the anterior intestinal portal and the morphogenesis of the heart tube. Sox17-null mutant embryos also showed defective differentiation of the cardiogenic mesoderm. These findings are consistent with the definitive endoderm being a source of morphogenetic cues that patterns the tissues associated with the gut (Lewis and Tam, 2006) ,
Results

Identification of Sox17-dependent changes in gene expression
To identify Sox17-dependent gene expression we compared the expression profile of Sox17-null mutant and wild type embryos at the 4-5 somite stage, in order to capture the changes in the transcriptome before the Sox17-null phenotype becomes morphologically evident (Kanai-Azuma et al., 2002) . This was expected to minimize the confounding effects caused by secondary changes in gene expression due to aberrant development. Among the up-regulated transcripts in the mutant embryos, there is a preponderance of those encoding apolipoproteins and solute transporters (Table 1, Supplementary Table S1 ). This is reflected in the over-representation of genes defined by Gene Ontology (GO) biological function terms relating to homeostasis, absorption, transport as well as cholesterol, steroid and lipid metabolism, catabolism and biosynthesis (Table 2A) . These genes include Apoa1, Apob, Apoc2, Apom and Slc2a2 that are known to be expressed primarily in the extraembryonic visceral endoderm during post-implantation development. Other genes that are expressed in the visceral endoderm were also upregulated in mutant embryos (including Afp, Cubn, Dab, Rbp4, Rhox5 and Ttr;  Table 1, Supplementary Table S1 ). Some of these putative visceral endoderm genes (e.g.: Afp, Ttr and Apo family members) are also expressed in the liver later in development but they are normally only expressed at low levels in the foregut endoderm of wild-type early-somite stage embryos. The profiling results are consistent with the observation that definitive endoderm is replaced by cells displaying phenotypes characteristic of the extraembryonic visceral endoderm in the embryonic gut region of the Sox17-null mutant (Kanai-Azuma et al., 2002) . Alternatively, it may be that one function of Sox17 is to maintain liver-specific gene expression at a low level in the early definitive endoderm.
Among the genes that were down-regulated in the mutant embryos (Table 3, Supplementary Table S1 ), there is an overrepresentation of genes involved in pathways for biosynthesis, metabolism and transport of lipids and cholesterol (Table 2B) . Transcripts of genes involved in cholesterol biosynthesis (Cyp51, Idi1, Insig1 and Sc4mol) and transport (Ldlr) showed reduced expression in the absence of Sox17, and downregulation was validated by qRT-PCR (Fig. 1) . Cholesterol is a key component of the Hedgehog signalling pathway that is essential for patterning the primitive gut tube (Harmon et al., 2002) . Notably, the concerted changes of the cholesterol pathway genes are consistent with the concept that cholesterogenic enzymes constitute a synexpression group in embryos and cultured fibroblasts (Iyer et Laubner et al., 2003; Marijanovic et al., 2003) . In the Sox17-null embryo, expression of Ihh in the gut endoderm and Ptch1 in the lateral plate mesoderm is down-regulated, indicating that loss of Sox17 function is associated with reduced Hedgehog signalling activity (Kanai-Azuma et al., 2002) . Also of note is the reduced expression of Nepn (Table 3, Supplementary Table S1) , which is normally expressed in the lateral midgut endoderm at this stage (Hou et al., 2007) . Its down-regulation is consistent with the depletion of definitive endoderm in the mutant embryos. Analysis of networks of transcriptional targets using Metacore (www.genego.com) revealed that 75 of the differentially expressed genes were also potentially regulated by Hnf4, with either a known effect on transcription or evidence for binding of Hnf4 to putative regulatory regions ( Supplementary Fig. S1 ). Hnf4 is expressed in liver and visceral endoderm suggesting a change in cell composition of the gut or dys-regulation of genes associated with liver development. Sox17 may also be regulated by Hnf4 via a cross-acting Hnf4 and Sox17 transcriptional networks.
To identify changes in Sox17-dependent gene expression without the complicating factor of altered tissue contents due to the loss of gene function, we over-expressed Sox17 in HepG2 hepatoma cells, an endoderm cell line of epithelial morphology which originates from the liver tissue. HepG2 cells were transfected with either a GFP expressing construct or a bi-cistronic construct expressing Sox17 along with a GFP reporter. Transfected cells were sorted for GFP expression, and expression Real-time quantitative RTPCR analysis was performed on cDNA generated from: (A) RNA samples of HepG2 cells transfected with GFP only or Sox17-IRES-GFP expression vector; and (B) RNA samples of 6-8 somite Sox17 +/+ and Sox17 +/-or Sox17 -/-embryos. Expression levels are shown relative to GFP only (A) or Sox17 +/-/ Sox17 +/-embryos (B). POLR2A was the reference gene for (A) and Gapd was the reference gene for (B). Error bars indicate standard error of the mean. N=4 for Sox17 +/+ , Sox17 +/-and N=3 for each all others. **Significant difference at p<0.01 or * at p<0.05 by two-tailed t-test from GFP-only expressing cells or Sox17 +/+ /Sox17 +/-embryos.
profiles analysed using Illumina human Sentrix-6 chips. Results were filtered for significantly different expression levels between GFP-only and Sox17-IRES-GFP transfected cells (Supplementary Table  S2 ). The list of differentially expressed genes was compared to the list of genes that were differentially expressed between wild-type and Sox17-mutant embryos, and we identified 32 genes that were differentially expressed in both sets of data (Table 4) . Of these, 21 showed concordance between the two data sets; that is, these genes were up-regulated in the HepG2 over-expressing Sox17 but down-regulated in Sox17-null embryos, and vice versa. These 21 genes are therefore potential candidates for positive or negative regulation by Sox17. Results of qRT-PCR have validated in the majority of cases the differential expression of these genes in transfected HepG2 cells ( Fig. 2A ) and in embryos (Fig. 2B) .
Two previous studies have addressed the question of Sox17-dependent gene expression either in mouse (Niakan et al., 2010) or human (Seguin et al., 2008) ES cells in which Sox17 was over-expressed. To gain additional insights into the genes that potentially act downstream of Sox17 we compared our embryo and HepG2 microarray data to these studies. Comparing the list of genes that were up-or down-regulated in Sox17-null embryos with those that were changed in the opposite direction in Sox17-over-expressing mouse (Niakan et al., 2010) and human (GEO accession GSE10809) ES cells revealed an overlap of 6 genes each in the embryo-mouse ES and embryohuman ES sets. These genes are involved in diverse processes including metabolism (folic acid, TCA, sorbitol, carbohydrate), cytoskeletal arrangement, transcription and cell proliferation (Supplementary Table S3A invagination) that forms the upper digestive tract and associated organs (Tremblay and Zaret, 2005) . In wild type and heterozygous mutant embryos, formation of the anterior intestinal portal proceeded first by invagination, followed by anterior extension and narrowing of the foregut pocket ( Fig. 4 A were no genes common to both sets. Most likely, this reflects the different effects of Sox17 over-expression in the two cell models.
In mouse ES cells, Sox17 appears to direct extraembryonic endoderm differentiation, whereas in human ES cells, Sox17 overexpression results in up-regulation of genes that are characteristic of definitive endoderm. Among the genes of the embryomouse ES and embryo-human ES sets, Adm, Fgb, Folr1 were also detected by ChIP from mouse ES or extraembryonic endoderm stem (XEN) cells (Niakan et al., 2010) suggesting that Sox17 may act directly on these genes.
Comparison of genes with changed expression levels in Sox17-mutant embryos and Sox17-overexpressing human ES cells (Seguin et al., 2008) revealed a set of genes that encode proteins that affect diverse processes including actin cytoskeleton organization (CDC42, RDX), proliferation and differentiation (FST, GNG4, SERPINE2) and responses to signalling (ACSL4, ADM, FST, GNG4, STC2; Supplementary Table S4 ). The best candidates Sox17-regulated genes in the definitive endoderm are those that are differentially expressed in Sox17-null embryos and in the over-expression HepG2 cells and to which Sox17 binds. Comparison with published data (Niakan et al., 2010) , (Supplementary  Table S5 ) revealed a set of six genes that fulfilled this criterion amongst those identified by ChIP of ES cells only (Fgb, Slco4c1), XEN cells only (Mbl2) or both ES and XEN cells (Adm, Nrp1, Rbm4b).
Sox17-deficient cells contribute less efficiently to gut endoderm
Our microarray studies revealed a higher representation of transcripts of genes that are characteristic of extraembryonic visceral endoderm in the Sox17-null embryo, suggesting a preponderance of this type of endoderm in the early-somite stage Sox17-null embryo. This is consistent with findings that Sox17 -/-embryo is depleted of definitive endoderm, which is partly replaced by cells that display properties of extraembryonic visceral endoderm (Kanai-Azuma et al., 2002) . To test directly whether Sox17-deficient progenitor cells are compromised in their ability to populate the gut endoderm, the fates of cells of the anterior segment of the primitive streak (APS) of gastrula-stage embryos, where the progenitors of definitive endoderm are localised (Kinder et al., 2000) , were analysed by orthotopic transplantation to wild type recipient embryos (Fig. 3 A, H) . Fluorescence imaging of the recipient embryos cultured for 29 hours revealed a widespread distribution of the EGFP and lacZ-expressing APS-derived cells from Sox17 +/+ and Sox17 +/-donor in the host embryos (Fig. 3 B , B', E, E') and to tissues derived from different germ layers (Fig. 3  C, D, F, G) . Although a similar average number of cells were generated by grafts of Sox17 -/-APS cells, a smaller proportion of graft-derived cells were found in the gut endoderm and the presomitic mesoderm (Fig. 3 I-N , Table 5 ). Instead, Sox17 -/-cells were found more frequently in the ectoderm of the posterior neural tube and the extraembryonic mesoderm (Table 5) . Sox17 -/-APS cells therefore are impaired in their ability to contribute to gut endoderm.
Morphogenesis of the anterior intestinal portal is disrupted in Sox17 -/-embryos
Cells of the anterior definitive endoderm cells are fated to become the endoderm of the anterior intestinal portal (the foregut 
GENES THAT WERE SIGNIFICANTLY DIFFERENTIALLY EXPRESSED IN SOX17 -/-EMBRYOS COMPARED TO WILD TYPE EMBRYOS AND IN SOX17-IRES-GFP TRANSFECTED HEPG2 CELLS COMPARED WITH GFP TRANSFECTED HEPG2 CELLS
Asterisk indicates genes that were up-regulated when Sox17 was over-expressed and down-regulated in its absence, and vice versa which led to the medial convergence and longitudinal extension of the lateral endoderm cell populations. Subsequently, these cells were found primarily in the lateral wall of the anterior intestinal portal (Fig 4 A, B left and right) . A unique morphogenetic feature of the anterior intestinal portal is the asymmetric displacement of the endoderm cells in the plane of the epithelium (Franklin et al., 2008) . This was observed in the wild type and Sox17 +/-mutant embryos in which cells from the left side of the portal were found on the floor (ventral wall) whereas those from the right side were found in the roof (dorsal wall) (Fig. 4 A , B left and right; Table 6 ). The Sox17 -/-embryos characteristically showed flattened neural folds and a shallow depression in the prospective foregut area at the initial phase of portal formation (Fig. 4C, 0hr) . The lateral regions of the portal were wider apart, resulting in a short portal and with a broad entrance (Fig. 4C, 23hr ). In addition, the lateral cell populations were mostly confined to the lateral walls and infrequently found asymmetrically on the dorsal or ventral wall of the portal (Fig. 4C , left and right; Table 6 ). Morphogenesis of the anterior intestinal portal in Sox17 -/-embryos is therefore defective with less convergence-extension and planar rotation of the anterior definitive endoderm.
Loss of Sox17 leads to down-regulation of cardiac genes and abnormal morphogenesis of the heart tube
Among the genes that were down-regulated in Sox17-null embryos, there was an over-representation of genes associated with heart development ( Table 2 ). In particular, Myocd, a transcription factor expressed in the heart tube (Wang et al., 2001) , is down-regulated significantly in early-somite stage Sox17 -/-embryos (Fig. 5A) . Whole mount in situ hybridisation revealed that 
Sox17 downstream effects 53
Examination the heart morphology of E8.5 Sox17-null embryos revealed abnormal heart tube phenotypes ranging from single heart tube that had not initiated looping (1/5) (Fig. 6B) , incomplete union of the heart tube (1/5) (Fig. 6C ) and the formation of two completely separated heart tubes (cardia bifida, 3/5) (Fig. 6D) . The heart of Sox17 +/-embryos (not shown) was indistinguishable from that of the wild type (Fig. 6A ). In the Sox17 mutant embryos the anterior intestinal portal was irregularly shaped and the floor crinkled extensively (Fig. 6 F, G, J) , in contrast to the uniform contour in the wild type embryo (Fig. 6E) . In Sox17 -/-mutant embryo with incomplete fusion or separated markers of the primary heart field (Myocd and Tbx5) and the secondary heart field (Isl1) are expressed in the cardiogenic mesoderm of Sox17 -/-embryos at the early head-fold stage (Fig.  5 B, D, F) , suggesting that the heart precursors were present in the embryo and that the initial distribution of the cardiogenic mesoderm to the heart field is not affected by the loss of Sox17 in the endoderm. However, Myocd and Tbx5 expression was absent from the midline tissues in the primary heart field of the Sox17 -/-embryos (3/4), resulting in a hiatus in the cardiac crescent where the lateral population of the heart progenitors failed to unite medially (Fig. 5 C-G) . heart tubes, the more caudal segment of the portal was open, resulting a wide ventral gap (Fig. 6  K, L) , which in the wild type embryo was closed by this stage (Fig.  6I) . The defects of heart tube formation in the Sox17-null mutant embryos are therefore accompanied by the abnormal morphogenesis of the anterior intestinal portal in addition to the defects in cardiac mesoderm differentiation.
Discussion
Sox17 downstream genes and molecular pathways
Microarray analysis of wild-type and Sox17-/-embryos revealed changes in expression of genes that are associated primarily with the definitive endoderm (Nepn, Foxa3, and Hnf4a) 
PATTERNS OF DISTRIBUTION OF CELLS ORIGINATING FROM THE LATERAL REGIONS OF THE ANTERIOR DEFINITIVE ENDODERM IN THE ANTERIOR INTESTINAL PORTAL
DiO labeled cells; DiI labeled cells. + Three out of five null-mutant embryos showed localization of the labeled cells only to the lateral wall of the anterior intestinal portal. Only 1/5 nullmutant as contrasted to 9/10 wild type or heterozygous embryos showed proper asymmetrical distribution of labeled cells: significant difference at P<0.01 by «2 test. * One each of null-mutant and wild type/heterozygous showed atypical localization of labeled cells from right side to the ventral wall (floor) instead of dorsal wall (roof). . Heart phenotype of E8.5 (7-8 somites) Sox17 -/-embryos. Wild type embryo shows a looping heart tube (A), whereas Sox17 -/-embryos display (B) un-looped heart tube, (C) partially united and (D) separate heart tube. Heart tissues are highlighted by Myocd expression by whole mount in situ hybridization (A-D) and in histological preparations (E-L, planes of sectioning indicated by arrowheads in A-D). The foregut of Sox17 -/-embryo has an abnormal shape (F, arrow) and an expanded corrugated floor (J, arrow) and opens ventrally (K, L: asterisk) in the posterior region of the foregut of embryos with bifid heart tube. ht: heart tube, fg: foregut.
changes in the expression of genes (e.g. heart development genes, cholesterol pathway genes) that are not associated with the endoderm. To identify transcripts that are candidates for direct dependence on Sox17 expression, we over-expressed Sox17 in HepG2 cells. As the liver is derived from the definitive endoderm, we reasoned that HepG2 cells would provide a cellular environment comparable to the gut endoderm of the mouse embryo, where Sox17 is normally expressed. Comparison of the results of the two array screens revealed a set of 21 genes whose changes in expression are consistent with either negative or positive regulation by Sox17. Analysis of publicly available gene expression data (http://biogps.gnf.org) revealed that 9 of these genes were specifically or predominantly expressed in adult and/or fetal liver (Afp, Apoc2, F10, Fga, Fgb, Fgg, Mbl2, Reep6 and Slc2a2) . All of these genes were found in our micrarray study to be downregulated in the Sox17-overexpressing HepG2 cells and upregulated in Sox17 -/-embryos. These data, along with the significant overlap with Hnf4a regulated genes, suggest the possibility that Sox17 plays a role in repression of liver-specific gene expression. This is consistent with a role for Sox17 in maintaining definitive endoderm in the progenitor state, and the reported requirement for Sox17 in the delineation of specific foregut endoderm-derived lineages, including the gallbladder and bile duct (Spence et al., 2009; Uemura et al., 2010) .
By comparing our mouse embryo and HepG2 micrarray expression data with ChIP data from mouse ES or XEN cells, we have identified a shortlist of six genes (Adm, Fgb, Mbl2, Nrp1, Rbm4b, Slco4c1) for which Sox17 influences their expression and there is evidence for binding of Sox17 protein to regulatory regions. These genes are diverse in function and expression and represent strong candidates for Sox17 transcriptional target genes.
Loss of Sox17 function impairs the allocation of endoderm cells
Although the Sox17-mutant phenotype indicates a role in the development of the definitive endoderm, several lines of evidence also point to a requirement of Sox17 in the differentiation of extraembryonic endoderm. In mouse ESC, enforced expression ofnSox17 promotes the differentiation of extraembryonic endoderm, whereas Sox17-null ES cells maintain the expression of pluripotency genes and fail to differentiate into extraembryonic endoderm. Stem cells with extraembryonic endoderm properties (XEN cells) cannot be generated from Sox17-null embryos (Niakan et al., 2010) . In contrast, in human ESC, progenitors with stable characteristics of definitive endoderm can be generated by constitutive expression of Sox17, whereas expression of another Group F Sox factor, Sox7, produces cells with more restricted potential reminiscent of the extraembryonic endoderm (Seguin et al., 2008) . Transcriptional profiling of SOX17 and SOX7 overexpressing human ESCs revealed that the sets of genes that were specifically upregulated by either SOX17 or SOX7 were far greater than the set of genes that was upregulated by both, indicating unique, tissue-specific roles for the two transcription factors. In agreement with these findings, our microarray data do not support a role for Sox17 in promoting extraembryonic endoderm differentiation in mouse embryos. Instead, our data show up-regulation of extraembryonic gene expression in Sox17-null embryos, consistent with apparent replacement of definitive endoderm with visceral endoderm-like cells (Kanai-Azuma et al., 2002) . Sox17-null ES cells are unable to contribute significantly to the definitive endoderm of the gut in the presence of wild type cells in the chimera (Kanai-Azuma et al., 2002) . Cell transplantation experiments performed in the present study further show that cells of the Sox17 -/-anterior primitive streak, where the endoderm progenitors are localised (Lawson et al., 1991) , are less efficient in contributing descendants to the host embryonic gut. The chimera and transplantation studies seem to show that, in addition to the maintenance of the lineage, Sox17 function may also play a role in, but not be essential for, the allocation of progenitors of the endoderm lineage. The elevated level of expression of many visceral endoderm genes in the Sox17-null embryos might result from the increased presence of extraembryonic endoderm which takes the place of the gut endoderm cells. This may be the result of not only the prevalence of apoptosis and reduced proliferative activity but also of the compromised ability of the mutant cells to contribute to the definitive endoderm.
Morphogenesis of the embryonic foregut and the heart tube is dependent on Sox17 function
Development of the embryonic foregut is initiated by the formation of the anterior intestinal portal beginning with the invagination of the anterior definitive endoderm underneath the head folds, accompanied by the longitudinal extension of the medial regions and the convergence of the lateral parts of the endoderm layer (Franklin et al., 2008 ). An intriguing feature of the morphogenesis of the portal is the pattern of movement of the contra-lateral endoderm populations of the prospective foregut. While these populations are undergoing longitudinal extension, they are also displaced asymmetrically along the wall of the portal: cells on the right populate the right and dorsal (roof) sides while cells on the left populate the left and ventral (floor) of the portal. The asymmetrical distribution of contra-lateral endoderm cells is accomplished by the directional relocation of cells within the epithelium that lines the portal and not due to the "rotation" of the foregut. However, the asymmetry of cell displacement corresponds with the laterality of subsequent rotation (left to ventral and right to dorsal) of the lower foregut. Sox17-null embryos form an anterior intestinal portal which is shorter and wider than the wild type counterpart, with excess folding of the floor and a split posterior ventral lip of the portal. Tracking the morphogenetic movement of anterior definitive endoderm in the null mutant embryo further revealed a much reduced longitudinal extension and medial convergence of the lateral endoderm, culminating in the distribution of these cells to wide lateral domain in the portal and very restricted rotational displacement.
Heart defects were not reported in the initial analysis of the Sox17-null phenotype (Kanai-Azuma et al., 2002) . A subsequent study revealed that the heart of the mutant embryo displayed defects in the looping of the heart tube (Sakamoto et al., 2007) . Our study further shows that Sox17-null mutant embryos display additional and more severe defects of the heart tube: lack of union of the cardiac precursors from the contra-lateral part of the cardiac crescent and bifid heart tubes. One possible cause of the difference in the manifestation of heart defects in our study and that of Sakamoto et al. (2007) is the difference in background. Whereas in the latter study, the mice were maintained on a mixed 129/Sv X C57BL/6 background, our mice have been maintained on a predominantly 129/Sv background. A precedent for the effect of genetic background on the heart defects is seen in Fibronectin 1 mutants which display less severe heart phenotype with an increasing contribution of C57/BL6 over the 129/Sv background (George et al., 1997) .
The formation of a wide portal with a ventral hiatus and the lack of asymmetrical displacement of the cells in the portal could be the morphogenetic factors underlying the incomplete fusion and lack of looping of the heart tube. Similar cardia bifida phenotypes found in other mouse and Zebrafish mutants are also accompanied by defects in foregut development, such as absence or reduction of foregut endoderm and incomplete closure of the foregut pocket Kuo et al., 1997; Li et al., 2004; Molkentin et al., 1997; Reiter et al., 1999; Roebroek et al., 1998) . It is not known whether the heart tube defects are due to the abnormal morphogenesis of the anterior intestinal portal and whether, in a broader context, the laterality in tissue movement in the anterior intestinal portal may predispose the direction of heart looping and the left-right asymmetry of the heart and the digestive tract.
Sox17 activity in the endoderm influences cardiac cell differentiation
In the mouse embryo, the cardiac cells are derived from two sources of progenitor cells: the primary and the secondary heart field. The primary heart field, consisting of Tbx5-and Myocdexpressing cells contributes to the left ventricle and atria. The secondary heart field, populating by Isl1-expressing cells, contributes to the outflow tract, right ventricle and atria and the pharyngeal mesoderm (Buckingham et al., 2005) . Expression profiling analysis reveals that loss of Sox17 is associated with the downregulation of Myocd expression. The heart-specific transcription factors Myocd, Tbx5 and Isl1 are expressed in the cardiac crescent. However, Myocd and Tbx5 are specifically down-regulated in the tissues at the vertex of the crescent. The domain where Myocd and Tbx5 expression is lacking corresponds to the region of defective union of the lateral cardiac progenitors in the midline. The cardia bifida phenotype in the absence of Sox17 is therefore most likely to be initiated by a failure in the fusion of the cardiac crescent at the midline leading to the formation of two separate lateral heart tubes. Our findings therefore suggest that Sox17 activity in the definitive endoderm is required for the induction Myocd-expressing cardiogenic mesoderm in a specific population of cells in the primary heart field that form the atria and part of the ventricle.
Sox17 has been shown to act in a non-cell autonomous manner in eliciting cardiac differentiation in mouse ES cells. Inhibition of Sox17 in mouse ES cells leads to a suppression of cardiac differentiation (Liu et al., 2007) . The expression of Sox17 in the foregut endoderm could therefore be required for the induction of heart-specific genes in the embryo. This may occur either by direct regulation of genes encoding signalling molecules or antagonists by Sox17, or indirectly with Sox17 playing a role in the maintenance or differentiation of the definitive endoderm, which then expresses the morphogenetic signals for heart development. Consistent with the non-cell autonomous role of Sox17 in heart development, overexpressed Sox17 in the pluripotent fibroblast cell line C3H10T1/2 does not induce Myocd expression (our unpublished data). On the other hand, co-culture of C3H10T1/2 with HepG2 cells does induce Myocd expression in the C3H10T1/2 cells, suggesting that the endoderm derived HepG2 cells are secreting a cardiac-inducing factor into the media. This is consistent with Sox17 playing an indirect role in heart induction. However, transfection of a Sox17 expression construct into the HepG2 cells does not result in increased Myocd expression in co-cultured C3H10T1/2 cells (F. Kruiswijk, DAFL and PPLT unpublished data) . In this case, the HepG2 cells are already primed to express the cardiac-inducing factor independently of Sox17 expression.
Materials and Methods
Mouse strains and genotyping
Sox17 mutant mice (Kanai-Azuma et al., 2002) were maintained on a 129/Sv background. Heterozygous Sox17 +/-mice were inter-crossed to generate wild type embryos, and heterozygous and homozygous mutant embryos for phenotypic analysis, expression studies and embryological experimentation. For testing the lineage potential of Sox17 -/-embryonic cells in the cell grafting experiment, Sox17 +/-mice were crossed with transgenic mice (H253) that co-express two transgenes (Hmgcr-nls-lacZ and pCAGG-EGFP) widely in embryonic tissues (Hadjantonakis et al., 1998; Kinder et al., 2001; Tam and Tan, 1992) to derive a line of Sox17 +/-;H253 mice (SGX). The SGX mice were inter-crossed to generate embryos of different Sox17 genotypes that express the transgenic reporters, so that the cells harvested from these embryos can be tracked during the course of the cell grafting experiment.
Microarray analyses
Total RNA from embryonic specimens was isolated using the RNeasy Micro Kit (QIAGEN) according to the manufacturer's instructions. RNA was isolated from two pairs of somite-number matched (4-5 somites) Sox17 -/-mutant and wild type embryos. The quality and quantity of the isolated RNAs were assessed on an Agilent Bioanalyser. RNA probes were amplified and labelled using the Affymetrix two-cycle process. Each RNA probe was hybridised to two or three Affymetrix GeneChip mouse genome 430 2.0 arrays, comprising all the known and predicted genes in the mouse genome. The arrays were read with an Affymetrix GS3000 scanner and raw data imported into Chipster v 1.4.4 (http://chipster.csc.fi) for normalization (RMA) and statistical analysis by linear modelling using LIMMA (significance at P<0.05), taking into account biological and technical replicates. Analysis of gene ontology was carried out within Chipster using a hypergeometric test for over-representation of terms.
HepG2 (Human hepatocellular carcinoma) cells were maintained in DMEM + 10 % FCS. Prior to transfection, approximately 2 x 10 6 cells were seeded into T75-flasks. One day later, the HepG2 cultures were transiently transfected with 8g of pCMV-Sox17-EGFP or CMV-EGFP control and 24 l FuGENE6 (Roche). After 48 hours the EGFP expressing cells were isolated using the flow cytometry (FACSVantage cell sorter). Total RNA was extracted from the cell pellets using the RNeasy Mini Kit (QIAGEN) according to the manufacturer's protocol. RNA samples from three independent groups of transfected cells were amplified, labelled and hybridised to Illumina Sentrix® Human-6 v2 Expression BeadChips that cover the human genome. The arrays were analysed with the Illumina BeadStation 500 reader. Beadstudio was used to normalize the data (cubic spline) and identify transcripts whose expression level had significantly changed (Illumina Custom test, p<0.01).
Quantitative real-time RT-PCR
RNA samples from Sox17 mutant and wild type embryos (4-5 somites) were reverse transcribed into cDNA using the SuperScript III First-Strand Synthesis System (Invitrogen). Real-time quantitative RT-PCR was performed on Rotor-Gene thermocyclers (Corbett Research) using QuantiTect SYBR Green (QIAGEN) or Platinum Taq (Invitrogen). Details of PCR primers are given in Supplementary Tables S6 and S7 .
Generation of riboprobes
To generate a plasmid from which to make a Myocd whole mount in situ hybridisation probe, a fragment was amplified from mouse E8.5 cDNA using Pfu DNA polymerase (Roche). Primer sequences for generating the 750bp probe were forward: 5'-TGGGCTAGACTCTGAGAAGGAC -3' and reverse: 5'-TGGGTGATATCTGAAACTGCTG-3'. The amplified fragments were subsequently cloned into pGEM-T (Promega) downstream of the T7 promoter. The Tbx5 antisense probe has been described previously (Chapman et al., 1996) . The Isl1 probe was kindly provided by Gerhard Przemeck (Helmholtz Zentrum München). For the generation of antisense RNA probes from linearized cDNA clones the DIG RNA labelling kit (Roche) has been used according to the manufacturer's instructions.
Whole mount in situ hybridisation
For whole mount in situ hybridisations embryos were fixed in 4% PFA in PBS over night, dehydrated in methanol and stored at -20ºC until usage. Whole mount in situ hybridisations were performed as described previously (Chapman et al., 1996; Davidson et al., 1999) . In brief, embryos were rehydrated in PBT (PBS plus 0.1% Tween-20), bleached with 6% hydrogen peroxide in PBT for 30min, washed in PBT, refixed in 4% PFA in PBS containing 0.2% glutaraldehyde for 20min and washed in PBT. Hybridisations with DIG-labelled antisense probes (1:200) were performed in hybridisation buffer (50% formamide, 5 x SSC pH4.5, 1% SDS, 50g/ml Heparin) at 70ºC over night. After two washes each in 2 x SSC, 0.1% SDS and 0.2 x SSC, 0.1% SDS at 70ºC, embryos were washed 3 times in MABT (100mM maleic acid pH 7.5, 150mM NaCl, 1% Tween-20, 2mM Levamisole). Embryos were blocked in 2% blocking reagent (Roche) in MABT for 1h, in 2% blocking reagent with 20% FCS in MABT for 1-3 h and incubated with alkaline phosphatase coupled anti-DIG antibody (Roche) (1:2000) in 2% blocking reagent with 20% FCS in MABT at 4ºC over night. After extensive washing in MABT for 1-3 days the embryos were washed twice in 2mM Levamisole, 0.1% Tween-20. BM purple AP substrate (Roche) was used for subsequent alkaline phosphatase staining. The embryos were kept in 4% PFA. After whole mount in situ hybridisations the embryos were dehydrated, embedded in paraffin wax and sectioned at 7m. The sections were counterstained with nuclear fast red and mounted using Canada balsam.
X-Gal staining of embryos
Embryos were washed twice in PBS, fixed in 4% PFA in PBS for 5min and washed again twice in PBS. In order to detect lacZ the embryos were stained in X-gal [5-bromo-5-chloro-3-indoyl--D-galactopyranoside] staining solution (1mg/ml X-gal, 5mM K 3 Fe(CN) 6 , 5mM K4Fe(CN) 6 , 2mM MgCl 2 , 0.01% Tween-20, 0.2% PFA in PBS) for 40 min at 37ºC. Afterwards the embryos were rinsed twice in PBS and fixed in 4% PFA in PBS over night. The stained embryos were processed for wax histology and the relative contribution of the graft-derived cells to various types of germ layer derivatives evaluated by scoring the number of X-gal stained cells in serial sections of the recipient embryos.
Cell transplantation
Embryos from SGX mating were collected at the E7.0 mid-streak stage. GFP positive embryos were selected as donors for transplantation. Tissue fragments from the anterior primitive streak of these embryos were isolated and further dissociated into small clumps of cells. The cell clumps were then transplanted to the anterior primitive streak of stage-matched wild type (ARC/s) embryos using a Leica micromanipulator. The remaining part of the embryo was collected for PCR genotyping. After grafting, the recipient embryos were checked by fluorescence microscopy for the correct placement of the transplanted cells. Embryos were cultured for 24-28h in a medium made up of 75% heat-inactivated rat serum and 25% Dulbecco's modified Eagle medium at 37C in glass bottles rotating at 30 RPM with a continuously replenished gas phase of 5% CO 2 , 20% O 2 and 75%N 2 (Sturm and Tam, 1993) . At the end of culture, recipient embryos were imaged by fluorescence photomicroscopy to visualise and record the distribution of the EGFP-expressing cells. Embryos containing EGFPexpressing graft-derived cells were then fixed in 4 % PFA and stained in X-gal staining solution to detect lacZ expression.
Dye labelling of the foregut endoderm
E7.0 mid-streak-stage embryos were harvested from pregnant mice generated by inter-crossing Sox17 +/-mice. Embryos were dissected from the decidua and the Reichert's membrane was removed. Embryos were selected by somite numbers to ensure stage-matching (1-3 somites) between groups of different Sox17 genotypes. They were kept in 100% rat serum in a 5%CO 2 incubator at 37C prior to micro-manipulation. For dye labelling, cells in the anterior definitive endoderm were painted with carbocyanine dyes: DiO (D275, Molecular Probes) and CM-DiI (C-7001, Molecular Probes) . In each embryo, around 100-150 cells each were labelled with one of the two dyes in order to reveal the relative spatial distribution of different cell populations and to track their morphogenetic movement during foregut morphogenesis. Following dye labelling, embryos were cultured for 12 hours under the same conditions as the cell grafting studies. Labelled embryos were imaged by fluorescence microscopy within 1 hour after labelling to ascertain the site of labelling. The embryos were re-imaged at the end of a 12-hour culture period to visualise the distribution of labelled cells in the embryonic gut. Photographs were taken using a Leica MZ16 microscope with a SPOT Advanced digital camera and fluorescent and bright field images were digitally edited and merged with the SPOT 4.0 software and Adobe Photoshop 7.0. The yolk sac of the embryo was collected to prepare the DNA for genotyping.
